ISSN: 2167-0846

Journal of Pain & Relief
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Case Report   
  • J Pain Relief,
  • DOI: 10.4172/2167-0846.1000536

Benefitted Reduction of Neuropathic and Non-Neuropathic Pain

Thomas H*
Department of Medicine, Universiti Sultan Zainal Abidin, Malaysia
*Corresponding Author : Thomas H, Department of Medicine, Universiti Sultan Zainal Abidin, Malaysia, Tel: 09874984103, Email: thoma@unimelb.edu.au

Received Date: Jul 19, 2023 / Published Date: Aug 21, 2023

Abstract

Muscle relaxant drugs include cyclobenzaprine, carisoprodol, chlorzoxazone, methocarbamol, and others. Cyclobenzaprine is essentially identical to amitriptyline, with potential adverse effects similar to those of amitriptyline. In addition, carisoprodol has been removed from the European market because of concerns about drug abuse. Although these drugs may relieve skeletal muscle pain, their effects are nonspecific and not related to muscle relaxation. Therefore, they should not be prescribed in the mistaken belief that they relieve muscle spasm.

Citation: Thomas H (2023) Benefitted Reduction of Neuropathic and Non- Neuropathic Pain. J Pain Relief 12: 536. Doi: 10.4172/2167-0846.1000536

Copyright: © 2023 Thomas H. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Post Your Comment Citation
Share This Article
Recommended Conferences
Article Usage
  • Total views: 547
  • [From(publication date): 0-2023 - Dec 23, 2024]
  • Breakdown by view type
  • HTML page views: 474
  • PDF downloads: 73
Top